AUPH - Aurinia Pharmaceuticals Inc Stock Trading

Aurinia Pharmaceuticals Inc(NASDAQ: AUPH) stock trading, description, contact, officers and directors.

About Aurinia Pharmaceuticals Inc

Not available

Stock Information

Aurinia Pharmaceuticals Inc Company Name:

AUPH Stock Symbol:

NASDAQ Market:

AUPH - Aurinia Pharmaceuticals Inc Stock Trading

Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...

AUPH - Aurinia Presents Data Demonstrating LUPKYNIS(TM) (voclosporin) Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings

Additional efficacy data from pooled analysis of AURA-LV and AURORA 1 pivotal trials demonstrate potential to improve renal response regardless of disease progression at diagnosis Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) today p...
AUPH - Aurinia Stock Has Great Potential, but It's Not a Buy Right Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia (NASDAQ: AUPH ) stock is a bet on a clinical-stage biotech firm tackling lupus nephritis with its drug, Lupkynis. Potential investors should note that the company is no longer in the developmental phases. ...
AUPH - Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS(TM) (voclosporin) in Latest ICER Draft Evidence Report

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) today announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS™ (voclosporin), based on an independent analysis issued by the Institute for Clinical and Economic...